phenyl-n-tert-butylnitrone has been researched along with oxotremorine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, G; Cutler, RC; Joseph, JA | 1 |
1 other study(ies) available for phenyl-n-tert-butylnitrone and oxotremorine
Article | Year |
---|---|
In vivo or in vitro administration of the nitrone spin-trapping compound, n-tert-butyl-alpha-phenylnitrone, (PBN) reduces age-related deficits in striatal muscarinic receptor sensitivity.
Topics: Aging; Animals; Cyclic N-Oxides; Dopamine; Muscarinic Agonists; Neostriatum; Nitrogen Oxides; Oxidative Stress; Oxotremorine; Potassium; Rats; Rats, Inbred F344; Sensitivity and Specificity; Spin Labels | 1995 |